Teva Pharmaceutical on Monday appointed former Novartis and Biogen executive Richard Francis to succeed chief executive officer Kare Schultz who is due to retire later this year.
executive Richard Francis to succeed chief executive officer Kare Schultz who is due to retire later this year.
Formerly the chief at Novartis' generic business Sandoz, Francis has also spent 13 years as a senior executive at Biogen, where he oversaw the launch of the company's multiple sclerosis drug Tecfidera. Schultz was poached from Lundbeck and took over in 2017 after Teva, under predecessor Erez Vigodman, bought Allergan's generics business in a heavily criticized move and saddled the company with a huge debt.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Disney CEO Swap: Bob Chapek Replaced By Previous CEO Bob IgerThe top spot at the world's biggest entertainment creator just flipped yet again.
続きを読む »
Starbucks pressured to keep toilets open to public by restroom nonprofit: 'Let the people go!'A nonprofit advocating for accessible public restrooms has called on Starbucks to keep its restrooms open to the public after CEO Howard Schultz suggested they might close them.
続きを読む »
Bob Iger returns as Disney CEO effective immediatelyHe replaces the man he had chosen to succeed him two years ago, BobChapek, whose brief tenure was tumultuous.
続きを読む »
Disney taps ex-CEO Bob Iger to return, set strategyThe Walt Disney Company has tapped its former CEO Bob Iger to return to head the company for two years, firing his successor Bob Chapek, who took the post in 2020
続きを読む »
Bob Iger is returning as Disney CEO in a dramatic shakeup | EngadgetBob Iger is returning as Disney CEO in a massive leadership shakeup, with current CEO Bob Chapek stepping down..
続きを読む »
Bill Ackman Endorses Crypto Project Helium, Discloses Crypto Holdings.billackman changes his stance on crypto, says he endorses controversial blockchain powered wireless network helium . By thesamreynolds
続きを読む »